Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Emergent Biosolutions
(NY:
EBS
)
9.480
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
478
Open
9.480
Bid (Size)
9.630 (1)
Ask (Size)
9.670 (1)
Prev. Close
9.480
Today's Range
9.480 - 9.480
52wk Range
1.420 - 15.10
Shares Outstanding
54,100,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement
November 22, 2024
Via
Benzinga
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
November 18, 2024
The week kicks off amidst significant market movements shaped by geopolitical and policy developments.
Via
Talk Markets
Topics
Stocks / Equities
Performance
YTD
+266.02%
+266.02%
1 Month
+6.16%
+6.16%
3 Month
+1.72%
+1.72%
6 Month
+100.85%
+100.85%
1 Year
+357.97%
+357.97%
More News
Read More
After Trump's Win, It's Time To Take Profits On Gold
November 11, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise
November 07, 2024
Via
Benzinga
Topics
Death
Exposures
Death
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
November 07, 2024
Via
Benzinga
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000
November 07, 2024
Via
Benzinga
Exposures
Fossil Fuels
Gold Gains 1%; Halliburton Posts Weak Q3 Results
November 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 07, 2024
Via
Benzinga
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
November 07, 2024
Via
Benzinga
The Post-Trump Victory Trade
November 07, 2024
Via
Benzinga
Topics
Government
Exposures
Political
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 07, 2024
Via
Benzinga
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
November 07, 2024
Via
Benzinga
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
November 07, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
November 06, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
November 06, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
November 04, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
October 23, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic
October 08, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
What's Going On With Emergent BioSolutions Stock Wednesday?
October 02, 2024
Via
Benzinga
Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
October 02, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
September 26, 2024
Via
Benzinga
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
September 26, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation
September 13, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
September 25, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.